含羞草社区

?
?
?
?
Home Tags Posts tagged with "Zhang Nan"

Tag: Zhang Nan

Pharma IPO Income Indicators and Risks
Practitioners' perspectives

Income indicators and risks for pharma IPOs

By Zhang Nan, W&H Law Firm

How income indicators and sales expenses impact risks in pharmaceutical IPOs under regulatory scrutiny

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

AI Content Labelling Rules

Of beauties and beasts: The digital dilemma

By Ashima Obhan and Shuchi Dutta, Obhan Mason
MSME Dispute Resolution India

Foreign investment and dispute resolution for MSMEs

By Shounak Mitra and Akshita Bohra, Khaitan & Co

How principal, interest are calculated and applied in court (Part 2)

By Chen Yanhong, DHH Law Firm

Taking TM’s measure

Trademark disputes, regulatory reforms and expansion pressures are forcing businesses to rethink brand protection

India Infrastructure PPP Reforms

How India is enabling faster, smoother project development

By Ashish Suman and M Arun Kumar, JSA
AnJie Broad hires Jessica Jiang

AnJie Broad hires construction and engineering partner

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW
Follow 含羞草社区
Law firms Awards Events Legal jobs ? Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 含羞草社区. All rights reserved.

Follow us on LinkedIn